Numbers of participants with different cancers evaluated in this study
| Total population (n=4231) | Non-cachexia (n=3380, %) | Cachexia (n=351, %) | |
| Lung cancer | 1179 | 1091 (92.5) | 88 (7.5) |
| Breast cancer | 942 | 916 (97.2) | 26 (2.8) |
| Colorectal cancer | 507 | 453 (89.3) | 54 (10.7) |
| Gastric cancer | 385 | 316 (82.1) | 69 (17.9) |
| Cervical cancer | 147 | 143 (97.3) | 4 (2.7) |
| Liver cancer | 142 | 137 (96.5) | 5 (3.5) |
| Oesophageal cancer | 121 | 95 (78.5) | 26 (21.5) |
| Ovarian cancer | 115 | 106 (92.2) | 9 (7.8) |
| Pancreatic cancer | 40 | 27 (67.5) | 13 (32.5) |
| Nasopharyngeal carcinoma | 24 | 21 (87.5) | 3 (12.5) |
| Multiple cancers | 42 | 35 (83.3) | 7 (16.7) |
| Other cancers | 587 | 540 (92.0) | 47 (8.0) |